Cambridge Trust CO Novartis Ag Transaction History

Cambridge Trust CO

  • $2.6 Billion
  • Q1 2024

A detailed history of Cambridge Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Cambridge Trust CO holds 213,554 shares of NVS stock, worth $22 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
213,554
Previous 300,050 28.83%
Holding current value
$22 Million
Previous $30.3 Million 31.82%
% of portfolio
0.8%
Previous 1.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024
SELL
$95.27 - $108.47 $8.24 Million - $9.38 Million
-86,496 Reduced 28.83%
213,554 $20.7 Million
Q4 2023

Jan 31, 2024
SELL
$92.27 - $101.54 $287,974 - $316,906
-3,121 Reduced 1.03%
300,050 $30.3 Million
Q3 2023

Oct 26, 2023
SELL
$94.73 - $105.13 $449,967 - $499,367
-4,750 Reduced 1.54%
303,171 $30.9 Million
Q2 2023

Jul 25, 2023
SELL
$92.52 - $104.91 $239,904 - $272,031
-2,593 Reduced 0.84%
307,921 $31.1 Million
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $188,070 - $218,103
-2,350 Reduced 0.75%
310,514 $28.6 Million
Q4 2022

Jan 09, 2023
BUY
$75.55 - $92.52 $1.82 Million - $2.22 Million
24,046 Added 8.33%
312,864 $28.4 Million
Q3 2022

Nov 07, 2022
SELL
$74.61 - $87.26 $179,362 - $209,773
-2,404 Reduced 0.83%
288,818 $22 Million
Q2 2022

Aug 16, 2022
BUY
$80.52 - $93.75 $978,962 - $1.14 Million
12,158 Added 4.36%
291,222 $24.6 Million
Q1 2022

May 12, 2022
BUY
$80.11 - $90.62 $487,549 - $551,513
6,086 Added 2.23%
279,064 $24.5 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $1.64 Million - $1.81 Million
-20,590 Reduced 7.01%
272,978 $23.9 Million
Q3 2021

Nov 23, 2021
BUY
$81.78 - $95.14 $246,321 - $286,561
3,012 Added 1.04%
293,568 $24 Million
Q3 2021

Nov 16, 2021
BUY
$81.78 - $95.14 $14.7 Million - $17.1 Million
179,663 Added 162.01%
290,556 $23.8 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $255,038 - $281,696
2,992 Added 2.77%
110,893 $10.1 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $168,586 - $198,810
2,019 Added 1.91%
107,901 $9.22 Million
Q4 2020

Jan 27, 2021
BUY
$78.07 - $94.43 $171,207 - $207,084
2,193 Added 2.11%
105,882 $10 Million
Q3 2020

Nov 03, 2020
BUY
$82.14 - $91.0 $50,516 - $55,965
615 Added 0.6%
103,689 $9.02 Million
Q2 2020

Aug 05, 2020
BUY
$80.93 - $91.1 $198,683 - $223,650
2,455 Added 2.44%
103,074 $8.67 Million
Q1 2020

May 04, 2020
BUY
$70.67 - $99.01 $112,859 - $158,118
1,597 Added 1.61%
100,619 $8.3 Million
Q4 2019

Feb 04, 2020
BUY
$84.35 - $95.37 $153,179 - $173,191
1,816 Added 1.87%
99,022 $9.38 Million
Q3 2019

Nov 06, 2019
BUY
$85.54 - $94.26 $2,138 - $2,356
25 Added 0.03%
97,206 $8.45 Million
Q2 2019

Jul 29, 2019
SELL
$75.4 - $92.8 $1.9 Million - $2.33 Million
-25,147 Reduced 20.56%
97,181 $0
Q1 2019

Apr 22, 2019
BUY
$75.32 - $86.15 $323,047 - $369,497
4,289 Added 3.63%
122,328 $11.8 Million
Q4 2018

Feb 04, 2019
BUY
$73.66 - $82.02 $698,738 - $778,041
9,486 Added 8.74%
118,039 $10.1 Million
Q3 2018

Oct 22, 2018
SELL
$66.94 - $77.43 $258,723 - $299,266
-3,865 Reduced 3.44%
108,553 $9.35 Million
Q2 2018

Aug 06, 2018
SELL
$64.91 - $73.36 $173,764 - $196,384
-2,677 Reduced 2.33%
112,418 $8.49 Million
Q1 2018

Apr 27, 2018
BUY
$70.39 - $84.15 $164,431 - $196,574
2,336 Added 2.07%
115,095 $9.31 Million
Q4 2017

Jan 24, 2018
SELL
$72.33 - $77.64 $249,321 - $267,625
-3,447 Reduced 2.97%
112,759 $0
Q3 2017

Nov 02, 2017
BUY
$74.14 - $77.27 $8.62 Million - $8.98 Million
116,206
116,206 $0

Others Institutions Holding NVS

# of Institutions
1,424
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $221B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email